Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Burkitt Lymphoma 19Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Biphenotypic, Acute 4Leukemia 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Blast Crisis 2Recurrence 1Philadelphia Chromosome 1Neoplasm, Residual 1Lymphoma 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Hematologic Neoplasms 1Down Syndrome 1

Interventions

venetoclax 4fludarabine 3gilteritinib 2aldesleukin 2Whole-Body Irradiation 2Interleukin-2 2Cytarabine 2Cyclophosphamide 2nicotinamide-beta-riboside 1fludarabine phosphate 1blinatumomab 1asciminib 1Thiotepa 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Mitoxantrone 1Methotrexate 1Idarubicin 1Hyperbaric Oxygenation 1Granulocyte Colony-Stimulating Factor 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Azacitidine 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Myeloid × blinatumomab × Clear all
NCT04260022 2025-11-05

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Ascentage Pharma Group Inc.

Phase 1 Recruiting
242 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Burkitt Lymphoma, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡